Skip to main content
Caplight Logo









MYNERVA AG

MYNERVA AG

Private
ZurichHealthcare & Life Scienceshttps://www.mynerva.com/

Last Round

Grant

Oct 31, 2025

Total Funding Raised

$5.96M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MYNERVA AG is a medical device company that develops wearable neuro-robotic technology to reduce chronic pain and restore the sense of touch in patients with diabetic peripheral neuropathy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuroprostheticdiabetic peripheral neuropathyDPNsmart sockwearable medical devicesensory restorationpain managementelectrical stimulationmedtechhealth IoTfall preventionbioelectronic medicinedigital healthneuromodulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MYNERVA AG Comparables

Compare MYNERVA AG with similar companies based on industry and business-model similarity.

MYNERVA AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Walk With Path
81%
RxFunction
79%
SensArs Neuroprosthetics
72%

MYNERVA AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 31, 2025
GrantJun 23, 2025
SeedSep 1, 2024
GrantNov 24, 2023
GrantSep 26, 2023

Key People

Founding team and executive leadership

Greta Preatoni

Chief Executive Officer

Executive Team

Luigi Carotenuto

Chief Technology Officer

Executive Team

MYNERVA AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 9, 2026

    Grew 33% QoQ from 12 to 16 employees.

  • Dec 23, 2025

    Grew 30% QoQ from 10 to 13 employees.

MYNERVA AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MYNERVA AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MYNERVA AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range16
Year Founded2025
Last FundingOct 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?